Skip to content

A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement

A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00940446
Enrollment
60
Registered
2009-07-16
Start date
2007-07-31
Completion date
2010-04-30
Last updated
2018-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bruising, Drainage, Erythema, Pain

Keywords

Insorb staples, Metal Staples

Brief summary

The purpose of this study is to compare the use of INSORB absorbable staples with metal staples on surgical incision healing after total hip replacement. The study evaluates wound healing, complications, and patient satisfaction regarding wound comfort and appearance after surgery.

Detailed description

Subcuticular closure of wounds can provide superior results to percutaneous suture closure due to the elimination of suture or staple tracts. These tracts can lead to infection and migration of epithelial cells adding to scarring, and cross-hatching scars which remain after healing. Absorbable staples can provide a rapid, secure, subcuticular closure of skin as an alternative to the traditional, manual staple or suture closure. This study will compare INSORB absorbable staples to externally applied standard metal staples with respect to effectiveness of incision closure, acute healing, subject comfort level, security and appearance after total hip replacement.

Interventions

DEVICEInsorb staples

absorbable staples required for wound closure

DEVICEmetal staples (Ethicon metal stapler)

wound closure with metal staples

Sponsors

OrthoIndy
CollaboratorOTHER
Orthopaedic Research Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient is 18 years or older * Patient or legal representative is able to understand and provide signed consent for the procedure * Patient is willing and able to return for required follow-up visits * Patient needs a total hip arthroplasty surgical procedure

Exclusion criteria

* Patient has an active infection * Patient is enrolled in another similar study * Patient has a known history of hepatitis * Patient has a known history of HIV * Patient has a known history of AIDs * Patient has a known history of IV drug abuse

Design outcomes

Primary

MeasureTime frameDescription
Participants With Incisional Drainage, Swelling or Gaps of IncisionDischarge from initial hospital stay (2-5 days post-op)Incisional drainage, swelling, gaps of incision. Drainage and swelling will be objectively determined by investigator. Gaps will be measured in millimeters.

Secondary

MeasureTime frameDescription
Participants With Wound Complications - Hematomaup to 6 weeks post-opAssessment of wound for complications, especially hematomas at 6 weeks post surgery. Participants will be scored based on presence of a hematoma or not.

Countries

United States

Participant flow

Participants by arm

ArmCount
Insorb Staples
Subcuticular Absorbable staples
30
Control
Metal staple wound closure
30
Total60

Baseline characteristics

CharacteristicInsorb StaplesControlTotal
Age, Continuous62.3 years61.9 years61.9 years
Number of staples placed465 staples597 staples1062 staples
Sex: Female, Male
Female
15 Participants20 Participants35 Participants
Sex: Female, Male
Male
15 Participants10 Participants25 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Participants With Incisional Drainage, Swelling or Gaps of Incision

Incisional drainage, swelling, gaps of incision. Drainage and swelling will be objectively determined by investigator. Gaps will be measured in millimeters.

Time frame: Discharge from initial hospital stay (2-5 days post-op)

ArmMeasureValue (NUMBER)
Insorb StaplesParticipants With Incisional Drainage, Swelling or Gaps of Incision10 participants
Control-metal StaplesParticipants With Incisional Drainage, Swelling or Gaps of Incision16 participants
Secondary

Participants With Wound Complications - Hematoma

Assessment of wound for complications, especially hematomas at 6 weeks post surgery. Participants will be scored based on presence of a hematoma or not.

Time frame: up to 6 weeks post-op

ArmMeasureValue (NUMBER)
Insorb StaplesParticipants With Wound Complications - Hematoma0 participants
Control-metal StaplesParticipants With Wound Complications - Hematoma1 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026